Roivant disclosed an insider sale worth $12,473,272, but the filing gives no reason and describes these reports as standard disclosures. It does not show a change in the company's business outlook.
The filing gives no reason for the sale, and the story calls these reports standard disclosures. It offers no information about a change in Roivant's business, so this filing alone does not change how we read the company.
Follow Roivant Sciences Ltd. (ROIV) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ROIV